Rani Therapeutics Holdings Inc. (RANI)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 70
+0.03
+4.0299%
$
42.39M Market Cap
- P/E Ratio
- Div Yield
1.19M Volume
-0.82 Eps
$ 0.67
Previous Close Want to track RANI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rani Therapeutics Holdings Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Farallon Capital Farallon Capital Management LLC | 78,000 | $105,300 | $51,737.4 | -$53,562.6 | -50.87% |
| RF Rekah Franca Catalyst Funds Management Pty Ltd. | 14,800 | $10,875 | $10,115.8 | -$759.2 | -6.98% |
 Li Peng China Universal Asset Management Co. Ltd. | 17,311 | $22,498.4 | $11,697.04 | -$10,801.36 | -48.01% |
 Christopher C. Powers Farther Finance Advisors, LLC | 13,800 | $18,630 | $9,622.74 | -$9,007.26 | -48.35% |
 Raymond Debbane Siren, L.L.C. | 2M | $2.7M | $1.34M | -$1.36M | -50.54% |
 Scott Schroeder Longaeva Partners LP | 2.33M | $3.01M | $1.61M | -$1.4M | -46.54% |
| TS Todd Stoner Disciplined Investors LLC | 12,200 | $16,470 | $8,516.82 | -$7,953.18 | -48.29% |
| GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd. | 2,175 | $2,740.64 | $1,585.14 | -$1,155.5 | -42.16% |
